Trial intelligence / Profile preview

Tinidazole for Mycoplasma Genitalium-Urethritis

NCT07088419Phase 2Recruiting

Sponsor
University of Washington
Start
Jul 2025
Primary completion
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tinidazole in Mycoplasma genitalium infection (Mgen), sponsored by University of Washington. Started Jul 2025; status: recruiting.

02

Drugs

tinidazole
03

Conditions

Mycoplasma genitalium infection (Mgen)

Beyond the preview

Go deeper on NCT07088419.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07088419.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call